Andy Sassine - Aug 15, 2023 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Chief Financial Officer, Director
Signature
/s/ Ilan Katz, attorney-in-fact
Stock symbol
ARCT
Transactions as of
Aug 15, 2023
Transactions value $
$21,248
Form type
4
Date filed
8/17/2023, 05:00 PM
Previous filing
Aug 8, 2023
Next filing
Nov 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARCT Common Stock Award $21.2K +1.22K +0.45% $17.37 271K Aug 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP").
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 16, 2022.